|
Code
|
Display
|
notes
|
vaccine-status
|
non-vaccine
|
last-updated
|
English (English, en)
|
|
54
|
adenovirus vaccine, type 4, live, oral |
|
inactive |
false |
2010-05-28 |
adenovirus, type 4 |
|
55
|
adenovirus vaccine, type 7, live, oral |
|
inactive |
false |
2010-05-28 |
adenovirus, type 7 |
|
82
|
adenovirus vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a adenovirus vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
adenovirus, unspecified formulation |
|
24
|
anthrax vaccine |
|
active |
false |
2019-06-11 |
anthrax |
|
19
|
Bacillus Calmette-Guerin vaccine |
|
active |
false |
2010-05-28 |
BCG |
|
27
|
botulinum antitoxin |
|
active |
true |
2020-09-04 |
|
|
26
|
cholera vaccine, unspecified formulation |
|
inactive |
false |
2016-06-17 |
cholera, unspecified formulation |
|
29
|
cytomegalovirus immune globulin, intravenous |
|
active |
true |
2020-09-04 |
CMVIG |
|
56
|
dengue fever vaccine |
Applies to dengue tetravalent product (e.g. DENGVAXIA) |
active |
false |
2019-09-24 |
dengue fever |
|
12
|
diphtheria antitoxin |
|
active |
true |
2020-09-04 |
|
|
28
|
diphtheria and tetanus toxoids, adsorbed for pediatric use |
|
active |
false |
2010-05-28 |
DT (pediatric) |
|
20
|
diphtheria, tetanus toxoids and acellular pertussis vaccine |
|
active |
false |
2010-05-28 |
DTaP |
|
106
|
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
|
active |
false |
2010-05-28 |
DTaP, 5 pertussis antigens |
|
107
|
diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a DTaP vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
DTaP, unspecified formulation |
|
110
|
DTaP-hepatitis B and poliovirus vaccine |
|
active |
false |
2010-05-28 |
DTaP-Hep B-IPV |
|
50
|
DTaP-Haemophilus influenzae type b conjugate vaccine |
|
inactive |
false |
2017-03-20 |
DTaP-Hib |
|
120
|
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
|
active |
false |
2010-05-28 |
DTaP-Hib-IPV |
|
130
|
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
|
active |
false |
2010-05-28 |
DTaP-IPV |
|
01
|
diphtheria, tetanus toxoids and pertussis vaccine |
|
inactive |
false |
2010-05-28 |
DTP |
|
22
|
DTP-Haemophilus influenzae type b conjugate vaccine |
|
inactive |
false |
2017-03-23 |
DTP-Hib |
|
102
|
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
This CVX has been corrected. This non-US vaccine contained DTP, Hib and Hep B. It was withdrawn in 2007 . |
non-US |
false |
2016-05-20 |
DTP-Hib-Hep B |
|
57
|
hantavirus vaccine |
|
never-active |
false |
2020-09-09 |
hantavirus |
|
52
|
hepatitis A vaccine, adult dosage |
|
active |
false |
2010-05-28 |
Hep A, adult |
|
83
|
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
|
active |
false |
2010-05-28 |
Hep A, ped/adol, 2 dose |
|
84
|
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
This vaccine formulation is inactive and should not be used, except to record historic vaccinations with this formulation. |
inactive |
false |
2010-05-28 |
Hep A, ped/adol, 3 dose |
|
31
|
hepatitis A vaccine, pediatric dosage, unspecified formulation |
Do NOT use this code. If formulation is unknown, use CVX 85. There is only one formulation of Hep A, peds. |
inactive |
false |
2010-09-30 |
Hep A, pediatric, unspecified formulation |
|
85
|
hepatitis A vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepA vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
Hep A, unspecified formulation |
|
104
|
hepatitis A and hepatitis B vaccine |
|
active |
false |
2010-05-28 |
Hep A-Hep B |
|
30
|
hepatitis B immune globulin |
|
active |
true |
2020-09-04 |
HBIG |
|
08
|
hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). It requires Merck's Recombivax HB adult formulation. Use code 43 for that vaccine. |
active |
false |
2018-05-10 |
Hep B, adolescent or pediatric |
|
42
|
hepatitis B vaccine, adolescent/high risk infant dosage |
As of August 27, 1998, Merck ceased distribution of their adolescent/high risk infant hepatitis B vaccine dosage. Code 42 should only be used to record historical records. For current administration of hepatitis B vaccine, pediatric/adolescent dosage, use code 08. |
inactive |
false |
2010-05-28 |
Hep B, adolescent/high risk infant |
|
43
|
hepatitis B vaccine, adult dosage |
As of September 1999, a 2-dose hepatitis B schedule for adolescents (11-15 year olds) was FDA approved for Merck's Recombivax HB adult formulation. Use code 43 for the 2-dose. This code should be used for any use of standard adult formulation of hepatitis B vaccine. |
active |
false |
2018-05-10 |
Hep B, adult |
|
44
|
hepatitis B vaccine, dialysis patient dosage |
NDCs that are used for both vaccine and dialysis (e.g. Engerix-B) are mapped to CVX 43 which is not specific to dialysis use |
active |
false |
2019-05-08 |
Hep B, dialysis |
|
45
|
hepatitis B vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepB vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
Hep B, unspecified formulation |
|
58
|
hepatitis C vaccine |
|
never-active |
false |
2020-09-09 |
Hep C |
|
59
|
hepatitis E vaccine |
|
never-active |
false |
2020-09-09 |
Hep E |
|
60
|
herpes simplex virus, type 2 vaccine |
|
never-active |
false |
2020-09-09 |
herpes simplex 2 |
|
46
|
Haemophilus influenzae type b vaccine, PRP-D conjugate |
|
inactive |
false |
2010-05-28 |
Hib (PRP-D) |
|
47
|
Haemophilus influenzae type b vaccine, HbOC conjugate |
|
inactive |
false |
2010-05-28 |
Hib (HbOC) |
|
48
|
Haemophilus influenzae type b vaccine, PRP-T conjugate |
|
active |
false |
2010-05-28 |
Hib (PRP-T) |
|
49
|
Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
|
active |
false |
2010-05-28 |
Hib (PRP-OMP) |
|
17
|
Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
|
inactive |
false |
2010-09-30 |
Hib, unspecified formulation |
|
51
|
Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
This vaccine may still be in use until the existing lots expire on 8/19/16. |
inactive |
false |
2016-03-11 |
Hib-Hep B |
|
61
|
human immunodeficiency virus vaccine |
|
never-active |
false |
2020-09-09 |
HIV |
|
118
|
human papilloma virus vaccine, bivalent |
|
inactive |
false |
2010-05-28 |
HPV, bivalent |
|
62
|
human papilloma virus vaccine, quadrivalent |
|
active |
false |
2020-06-02 |
HPV, quadrivalent |
|
86
|
immune globulin, intramuscular |
|
active |
true |
2020-09-04 |
IG |
|
87
|
immune globulin, intravenous |
|
active |
true |
2020-09-04 |
IGIV |
|
14
|
immune globulin, unspecified formulation |
|
inactive |
true |
2020-09-04 |
IG, unspecified formulation |
|
111
|
influenza virus vaccine, live, attenuated, for intranasal use |
LAIV3 |
inactive |
false |
2014-09-22 |
influenza, live, intranasal |
|
15
|
influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
This code is being retired. It will still be found in older immunization records. It included both preservative free and non-preservative free. |
inactive |
false |
2010-09-30 |
influenza, split (incl. purified surface antigen) |
|
16
|
influenza virus vaccine, whole virus |
|
inactive |
false |
2010-05-28 |
influenza, whole |
|
88
|
influenza virus vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a Influenza vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
influenza, unspecified formulation |
|
123
|
influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
|
inactive |
false |
2010-05-28 |
influenza, H5N1-1203 |
|
10
|
poliovirus vaccine, inactivated |
|
active |
false |
2010-05-28 |
IPV |
|
02
|
trivalent poliovirus vaccine, live, oral |
This is the OPV that was used in the US |
inactive |
false |
2017-02-10 |
OPV |
|
89
|
poliovirus vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a polio vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
polio, unspecified formulation |
|
39
|
Japanese Encephalitis Vaccine SC |
|
inactive |
false |
2015-09-24 |
Japanese encephalitis SC |
|
63
|
Junin virus vaccine |
|
never-active |
false |
2020-09-09 |
Junin virus |
|
64
|
leishmaniasis vaccine |
|
never-active |
false |
2020-09-09 |
leishmaniasis |
|
65
|
leprosy vaccine |
|
never-active |
false |
2020-09-09 |
leprosy |
|
66
|
Lyme disease vaccine |
|
inactive |
false |
2010-05-28 |
Lyme disease |
|
03
|
measles, mumps and rubella virus vaccine |
|
active |
false |
2010-05-28 |
MMR |
|
04
|
measles and rubella virus vaccine |
|
inactive |
false |
2010-05-28 |
M/R |
|
94
|
measles, mumps, rubella, and varicella virus vaccine |
|
active |
false |
2010-05-28 |
MMRV |
|
67
|
malaria vaccine |
|
never-active |
false |
2020-09-09 |
malaria |
|
05
|
measles virus vaccine |
|
inactive |
false |
2010-08-31 |
measles |
|
68
|
melanoma vaccine |
|
never-active |
false |
2020-09-09 |
melanoma |
|
32
|
meningococcal polysaccharide vaccine (MPSV4) |
|
inactive |
false |
2017-10-27 |
meningococcal MPSV4 |
|
103
|
meningococcal C conjugate vaccine |
|
inactive |
false |
2010-05-28 |
meningococcal C conjugate |
|
114
|
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
|
active |
false |
2010-05-28 |
meningococcal MCV4P |
|
108
|
meningococcal ACWY vaccine, unspecified formulation |
This CVX is intended for use when one of the meningococcal vaccines containing serogroups A, C, W and Y (conjugate or polysaccaride) was given and the exact formulation was not recorded. It should not be used to record newly administered immunizations. It is not to be used when one of the meningococcal vaccines containing other serogroups was administered. |
inactive |
false |
2015-12-01 |
meningococcal ACWY, unspecified formulation |
|
07
|
mumps virus vaccine |
|
inactive |
false |
2015-06-18 |
mumps |
|
69
|
parainfluenza-3 virus vaccine |
|
inactive |
false |
2010-05-28 |
parainfluenza-3 |
|
11
|
pertussis vaccine |
|
inactive |
false |
2010-05-28 |
pertussis |
|
23
|
plague vaccine |
|
inactive |
false |
2018-05-17 |
plague |
|
33
|
pneumococcal polysaccharide vaccine, 23 valent |
|
active |
false |
2010-05-28 |
pneumococcal polysaccharide PPV23 |
|
100
|
pneumococcal conjugate vaccine, 7 valent |
|
inactive |
false |
2014-06-26 |
pneumococcal conjugate PCV 7 |
|
109
|
pneumococcal vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a pneumococcal vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
pneumococcal, unspecified formulation |
|
70
|
Q fever vaccine |
|
never-active |
false |
2020-09-09 |
Q fever |
|
18
|
rabies vaccine, for intramuscular injection RETIRED CODE |
This CVX code has been retired. It is replace by CVX 175, or CVX 176. It will continue to be found in historic records. |
inactive |
false |
2016-10-18 |
rabies, intramuscular injection |
|
40
|
rabies vaccine, for intradermal injection |
|
inactive |
false |
2015-06-18 |
rabies, intradermal injection |
|
90
|
rabies vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a rabies vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
rabies, unspecified formulation |
|
72
|
rheumatic fever vaccine |
|
never-active |
false |
2020-09-09 |
rheumatic fever |
|
73
|
Rift Valley fever vaccine |
|
never-active |
false |
2020-09-09 |
Rift Valley fever |
|
34
|
rabies immune globulin |
|
active |
true |
2020-09-04 |
RIG |
|
119
|
rotavirus, live, monovalent vaccine |
|
active |
false |
2010-05-28 |
rotavirus, monovalent |
|
122
|
rotavirus vaccine, unspecified formulation |
|
inactive |
false |
2010-09-30 |
rotavirus, unspecified formulation |
|
116
|
rotavirus, live, pentavalent vaccine |
|
active |
false |
2010-05-28 |
rotavirus, pentavalent |
|
74
|
rotavirus, live, tetravalent vaccine |
|
inactive |
false |
2010-05-28 |
rotavirus, tetravalent |
|
71
|
respiratory syncytial virus immune globulin, intravenous |
|
active |
true |
2020-09-04 |
RSV-IGIV |
|
93
|
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
|
active |
true |
2020-09-04 |
RSV-MAb |
|
06
|
rubella virus vaccine |
|
inactive |
false |
2015-06-18 |
rubella |
|
38
|
rubella and mumps virus vaccine |
|
inactive |
false |
2010-05-28 |
rubella/mumps |
|
76
|
Staphylococcus bacteriophage lysate |
|
inactive |
true |
2020-09-04 |
Staphylococcus bacterio lysate |
|
113
|
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
|
active |
false |
2017-10-27 |
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
|
09
|
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
|
active |
false |
2017-10-27 |
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed |
|
115
|
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
|
active |
false |
2010-05-28 |
Tdap |
|
35
|
tetanus toxoid, adsorbed |
|
inactive |
false |
2015-08-14 |
|
|
112
|
tetanus toxoid, unspecified formulation |
|
inactive |
false |
2010-09-30 |
|
|
77
|
tick-borne encephalitis vaccine |
|
non-US |
false |
2017-10-27 |
tick-borne encephalitis |
|
13
|
tetanus immune globulin |
|
active |
true |
2020-09-04 |
TIG |
|
95
|
tuberculin skin test; old tuberculin, multipuncture device |
TB Skin test is not vaccine. |
inactive |
true |
2020-09-04 |
TST-OT tine test |
|
96
|
tuberculin skin test; purified protein derivative solution, intradermal |
TB Skin test is not vaccine. |
inactive |
true |
2020-09-04 |
TST-PPD intradermal |
|
97
|
tuberculin skin test; purified protein derivative, multipuncture device |
TB Skin test is not vaccine. |
inactive |
true |
2020-09-04 |
TST-PPD tine test |
|
98
|
tuberculin skin test; unspecified formulation |
TB Skin test is not vaccine. |
inactive |
true |
2020-09-04 |
TST, unspecified formulation |
|
78
|
tularemia vaccine |
|
inactive |
false |
2010-05-28 |
|
|
91
|
typhoid vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a typhoid vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
typhoid, unspecified formulation |
|
25
|
typhoid vaccine, live, oral |
|
active |
false |
2010-05-28 |
typhoid, oral |
|
41
|
typhoid vaccine, parenteral, other than acetone-killed, dried |
|
inactive |
false |
2015-08-13 |
typhoid, parenteral |
|
53
|
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
|
inactive |
false |
2015-06-18 |
typhoid, parenteral, AKD (U.S. military) |
|
101
|
typhoid Vi capsular polysaccharide vaccine |
|
active |
false |
2010-05-28 |
typhoid, ViCPs |
|
75
|
vaccinia (smallpox) vaccine |
|
active |
false |
2010-05-28 |
vaccinia (smallpox) |
|
105
|
vaccinia (smallpox) vaccine, diluted |
|
inactive |
false |
2010-05-28 |
vaccinia (smallpox) diluted |
|
79
|
vaccinia immune globulin |
|
active |
true |
2020-09-04 |
|
|
21
|
varicella virus vaccine |
|
active |
false |
2010-05-28 |
varicella |
|
81
|
Venezuelan equine encephalitis, inactivated |
|
inactive |
false |
2010-05-28 |
VEE, inactivated |
|
80
|
Venezuelan equine encephalitis, live, attenuated |
|
inactive |
false |
2010-05-28 |
VEE, live |
|
92
|
Venezuelan equine encephalitis vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a VEE vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
VEE, unspecified formulation |
|
36
|
varicella zoster immune globulin |
|
active |
true |
2020-09-04 |
VZIG |
|
117
|
varicella zoster immune globulin (Investigational New Drug) |
|
never-active |
true |
2020-09-09 |
VZIG (IND) |
|
37
|
yellow fever vaccine |
This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin. |
active |
false |
2017-03-02 |
yellow fever |
|
121
|
zoster vaccine, live |
|
active |
false |
2010-05-28 |
zoster live |
|
998
|
no vaccine administered |
Code 998 was added for use in VXU HL7 messages where the OBX segment is nested with the RXA segment, but the message does not contain information about a vaccine administration. An example of this use is to report the vaccines due next for a patient when no vaccine administration is being reported. |
inactive |
true |
2010-05-28 |
|
|
999
|
unknown vaccine or immune globulin |
This CVX code has little utility and should rarely be used. |
inactive |
true |
2020-10-27 |
unknown |
|
99
|
RESERVED - do not use |
Code 99 will not be used in this table to avoid confusion with code 999. |
inactive |
true |
2020-09-09 |
|
|
133
|
pneumococcal conjugate vaccine, 13 valent |
|
active |
false |
2010-05-28 |
Pneumococcal conjugate PCV 13 |
|
134
|
Japanese Encephalitis vaccine for intramuscular administration |
|
active |
false |
2010-05-28 |
Japanese Encephalitis IM |
|
137
|
HPV, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HPV vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
|
|
136
|
meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
|
active |
false |
2010-05-28 |
Meningococcal MCV4O |
|
135
|
influenza, high dose seasonal, preservative-free |
|
active |
false |
2010-05-28 |
Influenza, high dose seasonal |
|
131
|
Historical record of a typhus vaccination |
|
inactive |
false |
2010-05-28 |
typhus, historical |
|
132
|
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
This is not the same as CVX 146, Hexavalent vaccine. |
inactive |
false |
2018-05-10 |
DTaP-IPV-HIB-HEP B, historical |
|
128
|
Novel influenza-H1N1-09, all formulations |
This code is used whenever the actual formulation is not determined or when aggregating all Novel H1N1 Influenza-09 immunizations for reporting to CRA. It should not be used for seasonal influenza vaccine that is not otherwise specified. (NOS) |
inactive |
false |
2010-08-28 |
Novel Influenza-H1N1-09, all formulations |
|
125
|
Novel Influenza-H1N1-09, live virus for nasal administration |
|
inactive |
false |
2010-08-28 |
Novel Influenza-H1N1-09, nasal |
|
126
|
Novel influenza-H1N1-09, preservative-free, injectable |
|
inactive |
false |
2010-08-28 |
Novel influenza-H1N1-09, preservative-free |
|
127
|
Novel influenza-H1N1-09, injectable |
|
inactive |
false |
2010-08-28 |
Novel influenza-H1N1-09 |
|
138
|
tetanus and diphtheria toxoids, not adsorbed, for adult use |
Note that this Td is not adsorbed. |
inactive |
false |
2010-09-30 |
Td (adult) |
|
139
|
Td(adult) unspecified formulation |
This CVX code allows reporting of a historic vaccination when the formulation is unknown (for example, when recording a Td vaccination when noted on a vaccination card) |
inactive |
false |
2019-08-27 |
|
|
140
|
Influenza, seasonal, injectable, preservative free |
IIV3. This vaccine code is one of two which replace CVX 15, influenza, split virus. |
active |
false |
2013-07-17 |
|
|
129
|
Japanese Encephalitis vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a JE vaccination when noted on a vaccination card) |
inactive |
false |
2010-09-30 |
Japanese Encephalitis, unspecified formulation |
|
141
|
Influenza, seasonal, injectable |
IIV3. This is one of two codes replacing CVX 15, which is being retired. |
active |
false |
2013-07-17 |
|
|
142
|
tetanus toxoid, not adsorbed |
|
inactive |
false |
2015-08-14 |
|
|
143
|
Adenovirus, type 4 and type 7, live, oral |
This vaccine is administered as 2 tablets. |
active |
false |
2011-03-20 |
Adenovirus types 4 and 7 |
|
144
|
seasonal influenza, intradermal, preservative free |
IIV3 |
active |
false |
2013-07-17 |
influenza, seasonal, intradermal, preservative free |
|
145
|
respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
|
never-active |
true |
2020-09-09 |
RSV-MAb (new) |
|
146
|
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
Note that this vaccine is different from CVX 132. |
active |
false |
2019-05-02 |
DTaP,IPV,Hib,HepB |
|
147
|
Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
This CVX should only be used for historical doses of meningococcal conjugate vaccine where the formulation is unknown (oligosaccharide vs polysaccharide). It is not the same as CVX 108, Meningococcal, unspecified formulation. This CVX is for unspecified Meningococcal conjugate vaccines. |
inactive |
false |
2012-02-08 |
meningococcal MCV4, unspecified formulation |
|
148
|
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
|
inactive |
false |
2018-05-11 |
Meningococcal C/Y-HIB PRP |
|
149
|
influenza, live, intranasal, quadrivalent |
new in 2012. LAIV4 |
active |
false |
2013-07-17 |
|
|
150
|
Influenza, injectable, quadrivalent, preservative free |
New in 2012. IIV4 |
active |
false |
2013-07-17 |
influenza, injectable, quadrivalent, preservative free |
|
151
|
influenza nasal, unspecified formulation |
This CVX should only be used for historical records where the formulation of nasal flu vaccine is not known. |
inactive |
false |
2013-01-28 |
|
|
152
|
Pneumococcal Conjugate, unspecified formulation |
This CVX should only be used for historical records where the formulation of pneumococcal conjugate vaccine is not known. |
inactive |
false |
2013-01-28 |
|
|
153
|
Influenza, injectable, Madin Darby Canine Kidney, preservative free |
ccIIV3 |
inactive |
false |
2016-06-24 |
Influenza, injectable, MDCK, preservative free |
|
154
|
Hepatitis A immune globulin |
Do not use this code. This product may be used for Hep A and other viral infections. The correct vaccine / CVX is 86 (IG). |
never-active |
true |
2020-09-09 |
Hep A, IG |
|
155
|
Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
RIV |
active |
false |
2013-07-17 |
influenza, recombinant, injectable, preservative free |
|
156
|
Rho(D) Immune globulin- IV or IM |
This immune globulin may be administered either IM or IV. |
active |
true |
2020-09-04 |
Rho(D)-IG |
|
157
|
Rho(D) Immune globulin - IM |
This immune globulin may be administered IM only. |
active |
true |
2020-09-04 |
Rho(D) -IG IM |
|
158
|
influenza, injectable, quadrivalent, contains preservative |
New in 2013. IIV4 |
active |
false |
2013-08-20 |
influenza, injectable, quadrivalent |
|
159
|
Rho(D) Unspecified formulation |
|
inactive |
true |
2020-09-04 |
Rho(D) - Unspecified formulation |
|
160
|
Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
Approved by FDA 2013, adjuvant is mixed at point of administration. |
active |
false |
2014-05-27 |
Influenza A monovalent (H5N1), ADJUVANTED-2013 |
|
801
|
AS03 Adjuvant |
This is the adjuvant that is packaged with H5N1 vaccine, adjuvanted |
active |
true |
2020-10-27 |
|
|
161
|
Influenza, injectable,quadrivalent, preservative free, pediatric |
|
active |
false |
2014-07-23 |
|
|
162
|
meningococcal B vaccine, fully recombinant |
|
active |
false |
2014-11-03 |
meningococcal B, recombinant |
|
163
|
meningococcal B vaccine, recombinant, OMV, adjuvanted |
|
active |
false |
2015-02-02 |
meningococcal B, OMV |
|
164
|
meningococcal B, unspecified formulation |
|
inactive |
false |
2014-11-03 |
meningococcal B, unspecified |
|
165
|
Human Papillomavirus 9-valent vaccine |
|
active |
false |
2014-12-11 |
HPV9 |
|
166
|
influenza, intradermal, quadrivalent, preservative free, injectable |
|
active |
false |
2014-12-15 |
influenza, intradermal, quadrivalent, preservative free |
|
167
|
meningococcal vaccine of unknown formulation and unknown serogroups |
This CVX is intended for use when any one of the meningococcal vaccines is recorded and there is no information about which serogroups are protected against. This code should not be used when a newly administered immunization is recorded. |
inactive |
false |
2015-12-01 |
meningococcal, unknown serogroups |
|
168
|
Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
|
active |
false |
2015-12-10 |
influenza, trivalent, adjuvanted |
|
169
|
Hep A, live attenuated-IM |
This vaccine is not available in the US. |
non-US |
false |
2016-05-10 |
Hep A, live attenuated |
|
170
|
non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
This CVX was split off from CVX 102, to correctly identify the contents of the vaccine. |
non-US |
false |
2016-05-20 |
DTAP/IPV/HIB - non-US |
|
171
|
Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
|
active |
false |
2016-06-16 |
Influenza, injectable, MDCK, preservative free, quadrivalent |
|
172
|
cholera, WC-rBS |
|
non-US |
false |
2016-06-17 |
|
|
173
|
cholera, BivWC |
|
non-US |
false |
2016-06-17 |
|
|
174
|
cholera, live attenuated |
|
active |
false |
2016-06-17 |
|
|
175
|
Human Rabies vaccine from human diploid cell culture |
|
active |
false |
2016-10-18 |
Rabies - IM Diploid cell culture |
|
176
|
Human rabies vaccine from Chicken fibroblast culture |
|
active |
false |
2016-10-18 |
Rabies - IM fibroblast culture |
|
177
|
pneumococcal conjugate vaccine, 10 valent |
This is a foreign vaccine |
non-US |
false |
2016-12-19 |
PCV10 |
|
178
|
Non-US bivalent oral polio vaccine (types 1 and 3) |
This is a non-US vaccine that may be seen in some immunization histories. |
non-US |
false |
2017-01-17 |
OPV bivalent |
|
179
|
Non-US monovalent oral polio vaccine, unspecified formulation |
This is a non-US vaccine that may be seen in some immunization histories. It is composed of either Type 1, Type 2 or Type 3 oral polio vaccine. |
non-US |
false |
2017-01-17 |
OPV ,monovalent, unspecified |
|
180
|
tetanus immune globulin |
This record duplicates CVX 13 (TIG). Do not use CVX 180. |
inactive |
true |
2020-09-09 |
|
|
181
|
anthrax immune globulin |
|
active |
true |
2020-09-04 |
|
|
182
|
Oral Polio Vaccine, Unspecified formulation |
This code represents an oral polio vaccine where the specific formulation is unknown. |
inactive |
false |
2017-01-17 |
OPV, Unspecified |
|
183
|
Yellow fever vaccine alternative formulation |
This vaccine is stabilized with sorbitol and lactose and has been used outside the US for some time. It will be made available in the US. |
active |
false |
2017-03-02 |
Yellow fever vaccine - alt |
|
184
|
Yellow fever vaccine, unspecified formulation |
|
inactive |
false |
2017-03-02 |
Yellow fever, unspecified formulation |
|
185
|
Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
|
active |
false |
2017-04-21 |
influenza, recombinant, quadrivalent,injectable, preservative free |
|
186
|
Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
|
active |
false |
2017-06-27 |
Influenza, injectable, MDCK, quadrivalent, preservative |
|
187
|
zoster vaccine recombinant |
|
active |
false |
2017-10-27 |
zoster recombinant |
|
188
|
zoster vaccine, unspecified formulation |
This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a zoster vaccination when noted on a vaccination card) |
inactive |
false |
2017-10-27 |
zoster, unspecified formulation |
|
189
|
Hepatitis B vaccine (recombinant), CpG adjuvanted |
|
active |
false |
2018-05-10 |
HepB-CpG |
|
190
|
Typhoid conjugate vaccine (non-US) |
|
non-US |
false |
2018-05-10 |
Typhoid conjugate vaccine (TCV) |
|
191
|
meningococcal A polysaccharide vaccine (non-US) |
|
non-US |
false |
2018-05-10 |
meningococcal A polysaccharide (non-US) |
|
192
|
meningococcal AC polysaccharide vaccine (non-US) |
|
non-US |
false |
2018-05-10 |
meningococcal AC polysaccharide (non-US) |
|
193
|
hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
e.g. Twinrix Junior available in Canada |
non-US |
false |
2018-08-21 |
Hep A-Hep B, pediatric/adolescent |
|
194
|
influenza, Southern Hemisphere, unspecified formulation |
This CVX code should be used to record administration of Southern Hemisphere influenza vaccine where formulation is unknown |
inactive |
false |
2020-07-16 |
Influenza, Southern Hemisphere |
|
195
|
Diphtheria, Tetanus, Poliomyelitis adsorbed |
This code should be used to document non-US vaccines for DT,IPV such as Revaxis |
non-US |
false |
2019-07-30 |
DT, IPV adsorbed |
|
196
|
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
Used when Td Lf specification is unknown |
active |
false |
2019-08-15 |
Td, adsorbed, preservative free, adult use, Lf unspecified |
|
197
|
influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free |
Target population 65 and older, starting season 2020/2021 |
active |
false |
2020-07-22 |
influenza, high-dose, quadrivalent |
|
200
|
influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
Pediatric dose for ages 6-35 months |
active |
false |
2020-05-06 |
influenza, Southern Hemisphere, pediatric, preservative free |
|
201
|
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
Represents single dose vial |
active |
false |
2020-05-06 |
influenza, Southern Hemisphere, preservative free |
|
202
|
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
Represents multi-dose vial |
active |
false |
2020-05-06 |
influenza, Southern Hemisphere, quadrivalent, with preservative |
|
198
|
Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
This represents the non-US pentavalent vaccine. Should be used for historic documentation in US |
non-US |
false |
2020-04-22 |
DTP-hepB-Hib Pentavalent Non-US |
|
203
|
meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free |
|
active |
false |
2020-05-27 |
meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate |
|
205
|
influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free |
|
active |
false |
2020-07-22 |
Influenza vaccine, quadrivalent, adjuvanted |
|
206
|
smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile) |
National Stockpile Only. FDA US Licensed products JYNNEOS (also brandnames IMVAMUNE, IMVANEX) |
active |
false |
2020-07-20 |
Smallpox monkeypox vaccine (National Stockpile) |
|
207
|
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose |
EUA 12/18/2020, 2-dose vaccine |
active |
false |
2020-12-22 |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose |
|
208
|
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
EUA 12/11/2020, 2-dose vaccine |
active |
false |
2020-12-12 |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
|
213
|
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
Unspecified code for COVID-19 not to be used to record patient administration |
inactive |
false |
2020-11-16 |
|
|
210
|
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
Potential EUA, 2-dose vaccine |
active |
false |
2021-01-26 |
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
|
212
|
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 ml |
Potential EUA, 1-dose vaccine |
active |
false |
2021-01-26 |
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
|
204
|
Ebola Zaire vaccine, live, recombinant, 1mL dose |
FDA Approval Pending |
active |
false |
2021-04-06 |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
|
214
|
Ebola, unspecified |
|
inactive |
false |
2021-04-06 |
|
|
211
|
SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose |
Pending FDA EUA Authorization |
active |
false |
2021-04-06 |
COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |